First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
Clinical trial NCT06410313 · RECRUITING
Trial details
- NCT number
- NCT06410313
- Sponsor
- Medinol Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-15
- Primary completion
- 2027-01-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.